Pleomorphic xanthoastrocytomas (PXAs) are a rare variety of WHO grade II gliomas in children and young adults. The common site of location of PXAs is temporal or cortical. We present a rare case of PXA presenting as anterior cranial fossa (ACF) base lesion. A 7-year-old male presented with a history of a single episode of generalized tonic-clonic seizures and anosmia of 1 year's duration. An MRI of the brain revealed a large solid and cystic tumor in the ACF base with leptomeningeal involvement. The origin of the tumor could not be made out. The patient underwent parasagittal frontal craniotomy and gross total resection of the tumor. The tumor was parenchymal, involving both frontal lobes. It seemed to have been arising from the olfactory groove region. The solid portion of the tumor was also adherent to the falx and basal dura. He recovered completely following surgery. The postoperative period was uneventful. Histopathology was suggestive of PXA with high mitotic index. There was no recurrence of tumor at 6 months' follow-up. He is under close follow-up and will be offered radiotherapy if the tumor recurs. No PXAs arising from this location have been reported previously, and it is important to be aware of this possibility in children presenting with seizures and MRI which shows a solid cystic lesion superficially located in the ACF base region.

1.
Marko N, Weil R: The molecular biology of WHO grade II gliomas. Neurosurg Focus 2013;34:E1.
2.
Louis D, Ohgaki H, Wiestler O, Cavenee W, Burger P, Jouvet A, Scheithauer B, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114:97-109.
3.
Kepes J, Rubinstein L, Eng L: Pleomorphic xanthoastrocytoma: a distinctive meningocerebral glioma of young subjects with relatively favorable prognosis. A study of 12 cases. Cancer 1979;44:1839-1852.
4.
Gonçalves V, Reis F, Queiroz L, França M Jr: Pleomorphic xanthoastrocytoma: magnetic resonance imaging findings in a series of cases with histopathological confirmation. Arq Neuropsiquiatr 2013;71:35-39.
5.
Perkins S, Mitra N, Fei W, Shinohara E: Patterns of care and outcomes of patients with pleomorphic xanthoastrocytoma: a SEER analysis. J Neurooncol 2012;110:99-104.
6.
Appin C, Brat D: Molecular genetics of gliomas. Cancer J 2014;20:66-72.
7.
Fouladi M, Jenkins J, Burger P, Langston J, Merchant T, Heideman R, Thompson S, Sanford A, Kun L, Gajjar A: Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neurooncology 2001;3:184-192.
8.
Vajtai I, Varga Z: pleomorphic xanthoastrocytoma (in Hungarian). Orv Hetil 1997;138:991-997.
9.
Rao A, Laack N, Giannini C, Wetmore C: Pleomorphic xanthoastrocytoma in children and adolescents. Pediatr Blood Cancer 2010;55:290-294.
10.
Lim S, Kim J, Kim S, Park E, Ra Y, Kim C: Prognostic factors and therapeutic outcomes in 22 patients with pleomorphic xanthoastrocytoma. J Korean Neurosurg Soc 2013;53:281-287.
11.
Katayama K, Asano K, Shimamura N, Ogasawara Y, Naraoka M, Ohkuma H, Kurose A: Case of pleomorphic xanthoastrocytoma with anaplastic features in the pineal gland. Brain Tumor Pathol 2013;30:242-246.
12.
Thakar S, Sai Kiran NA, Ghosal N, Hegde AS: Pleomorphic xanthoastrocytoma: a new differential diagnosis for a pediatric pineal neoplasm. Brain Tumor Pathol 2012;29:168-171.
13.
Srinivas BH, Uppin MS, Panigrahi MK, Vijaya Saradhi M, Jyotsna Rani Y, Challa S: Pleomorphic xanthoastrocytoma of the pineal region. J Clin Neurosci 2010;17:1439-1441.
14.
Klein O, Grignon Y, Pinelli C, Civit T, Auque J, Marchal JC: Pleomorphic xanthoastrocytoma. A review of five observations (in French). Neurochirurgie 2004;50:515-520.
15.
Arita K, Kurisu K, Tominaga A, Sugiyama K, Sumida M, Hirose T: Intrasellar pleomorphic xanthoastrocytoma: case report. Neurosurgery 2002;51:1079-1082.
16.
Das S, Yip S, Hukin J, Cochrane D, Dunham C: Pleomorphic xanthoastrocytoma of the spinal cord: case report and literature review. Clin Neuropathol 2014;190-196.
17.
Gallo P, Cecchi P, Locatelli F, Rizzo P, Ghimenton C, Gerosa M, Pinna G: Pleomorphic xanthoastrocytoma: long-term results of surgical treatment and analysis of prognostic factors. Br J Neurosurg 2013;27:759-764.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.